Analysts See $-0.04 EPS for TSO3 Inc. (TOS)

Analysts expect TSO3 Inc. (TSE:TOS) to report $-0.04 EPS on November, 5.They anticipate $0.01 EPS change or 33.33 % from last quarter’s $-0.03 EPS. After having $-0.06 EPS previously, TSO3 Inc.’s analysts see -33.33 % EPS growth. The stock increased 0.59% or $0.0025 during the last trading session, reaching $0.4275. About 76,925 shares traded. TSO3 Inc. (TSE:TOS) has 0.00% since October 7, 2018 and is . It has by 0.00% the S&P500.

TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices. The company has market cap of $39.98 million. The company's principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. It currently has negative earnings. It also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes; and STERIZONE CI+ chemical indicator in Canada.

Another recent and important TSO3 Inc. (TSE:TOS) news was published by which published an article titled: “Investors Who Bought TSO3 (TSE:TOS) Shares Three Years Ago Are Now Down 88% – Yahoo Finance” on July 04, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.